These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 8924539)
1. [Do 5HT-3 receptor antagonists ameliorate cholestatic pruritus?]. Porcel JM; Vives M; Cano M; Rubio-Caballero M An Med Interna; 1995 Aug; 12(8):411. PubMed ID: 8924539 [No Abstract] [Full Text] [Related]
2. 5HT3 receptor antagonists and pruritus due to cholestasis. Quigley C Palliat Med; 1996 Jan; 10(1):54. PubMed ID: 8821191 [No Abstract] [Full Text] [Related]
3. [Ondansetron for cholestatic pruritus]. Lamelo Alfonsín F; Vila Arias M; San Martín Moreira J; Silva César M An Med Interna; 1998 Aug; 15(8):456. PubMed ID: 9780438 [No Abstract] [Full Text] [Related]
4. Treatment of cholestatic itching in primary biliary cirrhosis with ondansetron. Di Martino M; Galanti B; Nardiello S Ital J Gastroenterol; 1995; 27(8):455. PubMed ID: 8775475 [No Abstract] [Full Text] [Related]
5. Pruritus in a patient with advanced cancer successfully treated with continuous infusion of granisetron. Porzio G; Aielli F; Narducci F; Cannita K; Piccolo D; Marchetti P Support Care Cancer; 2004 Mar; 12(3):208-9. PubMed ID: 14735336 [TBL] [Abstract][Full Text] [Related]
6. The role of ondansetron in the management of cholestatic or uremic pruritus--a systematic review. To TH; Clark K; Lam L; Shelby-James T; Currow DC J Pain Symptom Manage; 2012 Nov; 44(5):725-30. PubMed ID: 22727254 [TBL] [Abstract][Full Text] [Related]
7. Ondansetron for pruritus in child with chronic cholestasis. Trioche P; Samuel D; Odièvre M; Labrune P Eur J Pediatr; 1996 Nov; 155(11):990. PubMed ID: 8911904 [No Abstract] [Full Text] [Related]
8. [The pathophysiology and treatment of cholestatic pruritus]. Wolfhagen FH; Engelkens HJ; van Buuren HR Ned Tijdschr Geneeskd; 1998 Mar; 142(13):688-92. PubMed ID: 9623140 [TBL] [Abstract][Full Text] [Related]
9. Efficacy of lidocaine in the treatment of pruritus in patients with chronic cholestatic liver diseases. Villamil AG; Bandi JC; Galdame OA; Gerona S; Gadano AC Am J Med; 2005 Oct; 118(10):1160-3. PubMed ID: 16194649 [No Abstract] [Full Text] [Related]
10. Relief of cholestatic pruritus by a novel class of drugs: 5-hydroxytryptamine type 3 (5-HT3) receptor antagonists: effectiveness of ondansetron. Schwörer H; Hartmann H; Ramadori G Pain; 1995 Apr; 61(1):33-37. PubMed ID: 7644246 [TBL] [Abstract][Full Text] [Related]
12. [Opiod antagonists and treatment of cholestatic pruritus]. Sapey T Gastroenterol Clin Biol; 1998 Feb; 22(2):255-6. PubMed ID: 9762206 [No Abstract] [Full Text] [Related]
13. [Cholestatic pruritus : new insights into pathophysiology and current treatment]. Kremer AE; Oude Elferink RP; Beuers U Hautarzt; 2012 Jul; 63(7):532-8. PubMed ID: 22733242 [TBL] [Abstract][Full Text] [Related]
14. Ondansetron and pruritus in chronic liver disease: a controlled study. Jones EA; Molenaar HA; Oosting J Hepatogastroenterology; 2007 Jun; 54(76):1196-9. PubMed ID: 17629069 [TBL] [Abstract][Full Text] [Related]
15. Effect of oral granisetron in uremic pruritus. Layegh P; Mojahedi MJ; Malekshah PE; Pezeshkpour F; Vahedian M; Nazemian F; Pour FS Indian J Dermatol Venereol Leprol; 2007; 73(4):231-4. PubMed ID: 17675729 [TBL] [Abstract][Full Text] [Related]
16. Propofol and cholestatic pruritus. Borgeat A; Wilder-Smith O; Mentha G; Huber O Am J Gastroenterol; 1992 May; 87(5):672-4. PubMed ID: 1595661 [TBL] [Abstract][Full Text] [Related]
17. [Cholestatic pruritus--pathophysiology and therapy with special reference to treatment with 5-hydroxytryptamine subtype 3 receptor antagonists]. Schwörer H; Ramadori G Z Gastroenterol; 1995 May; 33(5):265-74. PubMed ID: 7610695 [TBL] [Abstract][Full Text] [Related]
19. [Pruritus in cancer: uncommon, but sometimes worse than the pain]. Zylicz Z; Krajnik M Ned Tijdschr Geneeskd; 1999 Sep; 143(39):1937-40. PubMed ID: 10526610 [TBL] [Abstract][Full Text] [Related]
20. Severe pruritus of cholestasis in disseminated cancer: developing a rational treatment strategy. A case report. Zylicz Z; Stork N; Krajnik M J Pain Symptom Manage; 2005 Jan; 29(1):100-3. PubMed ID: 15652443 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]